February 24, 2021
Video
Unhealthy lifestyles during the pandemic may increase the risk of cardiovascular disease.
February 17, 2021
Article
Researchers find a significant benefit at day 28 when compared to a group taking a placebo.
February 16, 2021
The approval was based on data from the PARAGON-HF study.
Dr. Khan discusses some of the risk factors associated with CHD.
February 11, 2021
Researchers believe identifying more risk factors could be beneficial in reducing cardiovascular disease.
February 05, 2021
Two experts offer perspectives on the importance and state of cardiovascular health in women.
January 20, 2021
The approval is the first indication for a new pathway of care—one which has been linked to reduced heart failure death and hospitalization.
January 14, 2021
The SOLOIST-WHF trial indicates that SGLT2 inhibition may lead to an overall reduction in cardiovascular-related deaths and hospitalizations.
December 16, 2020
The agency is expected to rule on the Novartis treatment in 2021.
December 02, 2020
2020 was the year when regulators, clinicians, and patients had no choice but to embrace the concept of wearable monitoring devices. But it’s been a long time coming for the technology class.
